文献速递神经MR

钆喷酸葡胺与钆布醇对小鼠脑内炎症促进的钆滞留及毒性影响的差异

Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
PubMed 文献 · Invest Radiol · 2022-04-21

本研究在多发性硬化小鼠模型(EAE)中比较线性钆喷酸葡胺与大环状钆布醇的钆滞留动力学及神经毒性。EAE小鼠脑内炎症促进两种对比剂钆滞留增加,钆布醇在观察期内有效清除,而钆喷酸葡胺滞留持续整个观察期;体外炎症条件下钆喷酸葡胺显示神经毒性而钆布醇未显示。

要点

  • EAE小鼠脑内炎症促进两种钆对比剂的钆滞留增加。
  • 炎症脑内钆布醇在观察期内有效清除,而钆喷酸葡胺滞留持续至末次注射后40天。
  • 体外炎症条件下钆喷酸葡胺显示神经毒性,钆布醇未显示。

核心结论

  • 在EAE模型中,神经炎症促进两种钆对比剂在脑内的钆滞留增加;炎症脑内大环状钆布醇在观察期内有效清除,而线性钆喷酸葡胺的钆滞留持续整个观察期;钆喷酸葡胺在体外神经元炎症模型中似乎具有神经毒性,而钆布醇未显示。

研究设计与样本

  • 使用实验性自身免疫性脑脊髓炎(EAE)小鼠模型(n=29)与健康对照小鼠(n=24),给予累积剂量20 mmol/kg体重的钆喷酸葡胺或钆布醇(10天内8次注射,每次2.5 mmol/kg),于基线及末次注射后第1、10、40天进行7 T磁共振成像,处死后用激光烧蚀-电感耦合等离子体质谱(ICP-MS)和ICP-MS分别评估脑与血钆含量,并用慢性器官型海马切片培养在对照或炎症(肿瘤坏死因子α 50 ng/μL)条件下评估钆诱导的神经毒性。

关键影像表现/征象

  • 定量T1 mapping显示,与健康对照相比,EAE脑在多次注射两种对比剂后T1弛豫时间显著降低。
  • 激光烧蚀-ICP-MS显示EAE脑在末次注射后第1、10、40天钆滞留高于健康对照。
  • 炎症小脑深部小脑核在末次钆喷酸葡胺注射后至第40天仍见钆滞留升高(EAE vs 健康对照,55.06 ± 0.16 μM vs 30.44 ± 4.43 μM)。
  • 钆布醇在炎症脑内呈较弥漫的钆分布,至第40天明显减少(小脑核:EAE vs 健康对照,0.38 ± 0.08 μM vs 0.17 ± 0.03 μM)。

诊断标准与关键数值

  • 体外活脑组织分析显示,50 mM钆喷酸葡胺孵育后细胞死亡率升高,而钆布醇未升高。
  • 钆喷酸葡胺的细胞毒性效应在炎症介质TNF-α存在时增加(有 vs 无TNF-α,3.15% ± 1.18% vs 2.17% ± 1.14%;P = 0.0345)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Using a murine model of multiple sclerosis, we previously showed that repeated administration of gadopentetate dimeglumine led to retention of gadolinium (Gd) within cerebellar structures and that this process was enhanced with inflammation. This study aimed to compare the kinetics and retention profiles of Gd in inflamed and healthy brains after application of the macrocyclic Gd-based contrast agent (GBCA) gadobutrol or the linear GBCA gadopentetate. Moreover, potential Gd-induced neurotoxicity was investigated in living hippocampal slices ex vivo.

MATERIALS AND METHODS: Mice at peak of experimental autoimmune encephalomyelitis (EAE; n = 29) and healthy control mice (HC; n = 24) were exposed to a cumulative dose of 20 mmol/kg bodyweight of either gadopentetate dimeglumine or gadobutrol (8 injections of 2.5 mmol/kg over 10 days). Magnetic resonance imaging (7 T) was performed at baseline as well as at day 1, 10, and 40 post final injection (pfi) of GBCAs. Mice were sacrificed after magnetic resonance imaging and brain and blood Gd content was assessed by laser ablation-inductively coupled plasma (ICP)-mass spectrometry (MS) and ICP-MS, respectively. In addition, using chronic organotypic hippocampal slice cultures, Gd-induced neurotoxicity was addressed in living brain tissue ex vivo, both under control or inflammatory (tumor necrosis factor α [TNF-α] at 50 ng/μL) conditions.

RESULTS: Neuroinflammation promoted a significant decrease in T1 relaxation times after multiple injections of both GBCAs as shown by quantitative T1 mapping of EAE brains compared with HC. This corresponded to higher Gd retention within the EAE brains at 1, 10, and 40 days pfi as determined by laser ablation-ICP-MS. In inflamed cerebellum, in particular in the deep cerebellar nuclei (CN), elevated Gd retention was observed until day 40 after last gadopentetate application (CN: EAE vs HC, 55.06 ± 0.16 μM vs 30.44 ± 4.43 μM). In contrast, gadobutrol application led to a rather diffuse Gd content in the inflamed brains, which strongly diminished until day 40 (CN: EAE vs HC, 0.38 ± 0.08 μM vs 0.17 ± 0.03 μM). The analysis of cytotoxic effects of both GBCAs using living brain tissue revealed an elevated cell death rate after incubation with gadopentetate but not gadobutrol at 50 mM. The cytotoxic effect due to gadopentetate increased in the presence of the inflammatory mediator TNF-α (with vs without TNF-α, 3.15% ± 1.18% vs 2.17% ± 1.14%; P = 0.0345).

CONCLUSIONS: In the EAE model, neuroinflammation promoted increased Gd retention in the brain for both GBCAs. Whereas in the inflamed brains, efficient clearance of macrocyclic gadobutrol during the investigated time period was observed, the Gd retention after application of linear gadopentetate persisted over the entire observational period. Gadopentetate but not gadubutrol appeared to be neurotoxic in an ex vivo paradigm of neuronal inflammation.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Anderhalten, Silva, Morr, et al. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain. Invest Radiol. 2022. PMID: 35467573. doi:10.1097/RLI.0000000000000884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。